Sruti Tekumalla
Papers
1
Total Citations
24
H-Index
1
About
Dr. Sruti Tekumalla is a rising leader in head and neck surgical oncology, with a focused expertise in the treatment of oropharyngeal squamous cell carcinoma (OPSCC). Her most impactful work addresses a critical clinical debate: the comparative effectiveness of primary transoral robotic surgery (TORS) versus primary chemoradiation for early-stage (T1-T2) OPSCC. In her highly cited 2023 study, which has garnered 24 citations, Dr. Tekumalla provided crucial real-world evidence on functional and survival outcomes where high-powered randomized trials are lacking. This contribution directly informs shared decision-making between surgeons and patients, helping to balance oncologic control with quality of life. By rigorously analyzing these competing treatment paradigms, she has helped clarify the nuanced benefits and risks of each approach. Dr. Tekumalla’s research is instrumental in advancing personalized care for head and neck cancer patients, bridging a critical gap in the literature and shaping future clinical guidelines. Her work continues to influence how multidisciplinary teams optimize treatment strategies for this complex disease.
Research Focus
Key Achievements
Top Papers
- 1